Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03251924
Title A Dose Escalation and Combination Immunotherapy Study to Evaluate BMS-986226 Alone or in Combination With Nivolumab or Ipilimumab in Patients With Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | CHE | CAN

Facility Status City State Zip Country Details
Local Institution - 0005 Boston Massachusetts 02215 United States Details
Local Institution - 0012 Saint Louis Missouri 63110 United States Details
Local Institution - 0002 Hackensack New Jersey 07601 United States Details
Local Institution - 0001 Philadelphia Pennsylvania 19111 United States Details
Local Institution - 0004 Nashville Tennessee 37203 United States Details
Local Institution - 0014 Edmonton Alberta T6G 1Z2 Canada Details
Local Institution - 0006 Hamilton Ontario L8V 5C2 Canada Details
Local Institution - 0003 Toronto Ontario M5G 2M9 Canada Details
Local Institution - 0007 Madrid 28040 Spain Details
Local Institution - 0008 Madrid 28050 Spain Details
Local Institution - 0009 Chur 7000 Switzerland Details
Local Institution - 0010 Lausanne 1011 Switzerland Details
Local Institution - 0011 Zuerich 8091 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field